| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on June 30, 2004
Accepted on December 20, 2004
Endocrine Division, Department of Internal Medicine, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Göteborg, Department of Endocrinology, Malmö University Hospital, Lund University, Malmö, Section of Preventive Cardiology, Göteborg University, Göteborg, Sweden
* To whom correspondence should be addressed. E-mail: kerstin.landin{at}sahlgrenska.se.
Turner syndrome (TS) is caused by a sex-chromosome aberration. The aim was to study the prevalence and incidence of thyroid disease in adults with TS.
Women with TS, n = 91, mean age 37.7 ± 11 yr, were compared with an age-matched female random-population sample, n = 228. At baseline, 15 (16%) TS women were treated for hypothyroidism and elevated serum thyroid stimulating hormone (TSH) was found in another 8 (9%). As a result, hypothyroidism was more common in TS, 25%, than in controls, 2% (P < 0.0001). Serum-free thyroxin was lower (P = 0.02) and serum TSH higher (P < 0.0001) in TS than in age-matched controls. Of all TS with hypothyroidism, 10 (43%) had an elevated thyroid peroxidase (TPO) antibody titer vs. 15 (22%) of those without hypothyroidism (P < 0.05), evenly distributed between the karyotype 45,X and mosaicism. A high body mass index, but not a family history or blood lipids, were associated with hypothyroidism in TS. After the five-year follow-up, a further 11 (16%) developed hypothyroidism, of whom 4 (36%) had elevated TPO. Altogether, 34 (37%) TS women had hypothyroidism after the five-year follow-up.
Autoimmune hypothyroidism was common, with an annual incidence of 3.2% in TS. Thyroid function should be checked regularly in TS.
This article has been cited by other articles:
![]() |
B. E. Hjerrild, K. H. Mortensen, and C. H. Gravholt Turner syndrome and clinical treatment Br. Med. Bull., June 1, 2008; 86(1): 77 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy and for The Turner Syndrome Consensus Study Group Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stochholm, S. Juul, K. Juel, R. W. Naeraa, and C. Hojbjerg Gravholt Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3897 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D C Donaldson, E J Gault, K W Tan, and D B Dunger Optimising management in Turner syndrome: from infancy to adult transfer Arch. Dis. Child., June 1, 2006; 91(6): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cakan and D. Kamat Commentary Clinical Pediatrics, March 1, 2006; 45(2): 192 - 195. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |